Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer
Authors:
Open Access
- 27 June 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 45 (2) , 262-267
Abstract
The clinical course from recurrence to cancer-related death after curative resection has not been clearly elucidated in non-small-cell lung cancer (NSCLC). This study examined the clinical outcomes after postoperative recurrence in patients with completely resected Stage I NSCLC. This study included patients who had recurrence after complete resection for pathological Stage I NSCLC between 2003 and 2009. Clinical data evaluated in this study included the diagnostic process of recurrence, recurrence pattern, treatment process and prognosis. A number of clinicopathological factors were analysed for post-recurrence survival by univariate and multivariate analyses. Seventy-two patients experienced recurrence during a median follow-up period of 37.5 months. Thirteen patients (18%) presented symptoms at the initial recurrence. Tumour markers, computed tomography (CT) and positron emission tomography/CT were chosen as the initial diagnostic tools and detected recurrences in 1 (1%), 51 (71%) and 7 (10%) patients, respectively. The mean recurrence-free interval (RFI) was 15.4 months (≤12 months in 34, >12 months in 38 patients). The patterns of recurrence were presented as loco-regional recurrence in 36 (50%) and distant metastasis in 36 patients (50%). Types of the initial treatment included operations in 28 (39%), chemotherapy and/or radiotherapy in 38 (53%) and radiofrequency ablation in 2 patients (3%). Four patients (6%) rejected treatment. Forty-three patients (62%) presented a good response to the initial treatment. Thirty-seven patients (51%) died, and the cause of death in all of these patients was cancer-related. The median survival duration after recurrence was 43.6 (1–136) months. Univariate analysis identified no recurrence of symptoms, a good response to treatment and a longer RFI as good prognostic factors, while a good response to treatment and a longer RFI were independent prognostic factors in multivariate analysis. Most postoperative recurrences were detected in an asymptomatic condition during the routine follow-up period, and a good response to initial treatment and a longer RFI were significant predictors of better post-recurrence survival in patients with completely resected Stage I NSCLC.Keywords
This publication has 19 references indexed in Scilit:
- Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasisThorax, 2010
- Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrenceThorax, 2009
- Postrecurrence survival in patients with stage I non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2008
- Treatment of Non-small Cell Lung Cancer Stage I and Stage IIChest, 2007
- Stage IB Nonsmall Cell Lung Cancers: Are They All the Same?The Annals of Thoracic Surgery, 2006
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- Disease recurrence after resection for stage I lung cancerEuropean Journal of Cardio-Thoracic Surgery, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrenceCancer, 1995
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995